Share

Shareholders support combination to create a leading, diversified CNS-focused biopharmaceutical company

On October 15, 2026, Indivior’s shareholders approved the proposed all-stock merger of equals with Supernus Pharmaceuticals, Inc. The proposal received strong support, with 94% of votes cast in favor of the transaction.

Shareholder approval marks an important milestone toward completing the merger, which was announced in August 2026. The transaction is expected to close on November 2, 2026. Following closing, the combined company will operate as Supernus, Inc., and trade on Nasdaq under the ticker symbol “SUPN.”

The combination will bring together two complementary organizations to create a leading, diversified and scaled biopharmaceutical company focused on central nervous system diseases. Together, the companies will be positioned to build on their respective strengths, expand their impact for patients, and create long-term value for shareholders.

For Further Information

Investors: 
Jason Thompson 
Indivior Pharmaceuticals
Tel: 804-402-7123 
E-mail: jason.thompson@indivior.com

Media: 
Cassie France-Kelly 
Indivior Pharmaceuticals
Tel: 804-594-0836 
E-mail: Indiviormediacontacts@indivior.com  

Privacy Preference Center

When you visit any website, it may store or retrieve information on your browser, mostly in the form of cookies. This information might be about you, your preferences or your device and is mostly used to make the site work as you expect it to. The information does not usually directly identify you, but it can give you a more personalized web experience. Because we respect your right to privacy, you can choose not to allow some types of cookies. Click on the different category headings to find out more and change our default settings. However, blocking some types of cookies may impact your experience of the site and the services we are able to offer.

Privacy Policy Cookie Notice

Manage Consent Preferences

Always Active

These cookies are essential for the website to function, such as navigating secure areas, remembering your privacy preferences, or keeping items in a shopping cart. They cannot be switched off.

These cookies help us understand how visitors interact with the website, allowing us to measure and improve performance (e.g., Google Analytics). Data is anonymized.

These cookies may be set through our site by our advertising partners. They may be used by those companies to build a profile of your interests and show you relevant adverts on other sites. They do not store directly personal information, but are based on uniquely identifying your browser and internet device. If you do not allow these cookies, you will experience less targeted advertising.